ICRP http://www.icrp.org/index.asp International Commission on Radiological Protection en-gb Sun, 22 Oct 2017 22:47:50 +0000 Summary of October 2017 Main Commission Meeting Paris http://www.icrp.org/docs/Summary of October 2017 Main Commission Meeting Paris.pdf http://www.irpa.net/docs/Summary of October 2017 Main Commission Meeting Paris.pdf Fri, 20 Oct 2017 11:04:08 +0000 ICRP-ERPW 2017 Link Now Available http://www.icrp.org/page.asp?id=364 <p>Whether you particiapted in last weeks ICRP-ERPW 2017 Symposium or not, related information of the event can now be found our <a href="page.asp?id=248">website</a>.</p> <p>Presentations, proceedings, the programme book, meeting summaries, and many other relevant pieces of information will all be cotinually updated over the coming weeks.</p> <p>Continue to check back in as more information becomes available!</p> Fri, 20 Oct 2017 16:25:29 +0000 ICRP Main Commission Elects New Chair of Committee 3 http://www.icrp.org/docs/ICRP Main Commission Elects New Chair of Committee 3.pdf http://www.irpa.net/docs/ICRP Main Commission Elects New Chair of Committee 3.pdf Sat, 14 Oct 2017 08:57:52 +0000 Proceedings of the ICRP Dialogue Initiative Now Available http://www.icrp.org/page.asp?id=363 <p>ICRP is pleased to annouce that the Proceedings of the International Workshop on the Fukushima Dialogue Initiative are now available on the <a href="http://journals.sagepub.com/doi/pdf/10.1177/ANIB_45_2S">Sage Website</a>.</p> <p>With focus on the rehabilitation of living conditions after the nuclear accident in 2011, the meetings in December 2015 are now free-to-access.</p> <p>The objective of the workshop was to share the experiences and main lessons of the ICRP Fukushima Dialogue inititiave, focusing on the 12 main dialogue meetings held between November 2011 and September of 2015 at various locations in Fukushima Prefecture.</p> <p>Further information about ICRP and Fukushima, outside of this publication, can be found on <a href="page.asp?id=188">www.icrp.org</a>.</p> <p class="MsoNormal">The workshop was organised by ICRP, hosted by Date City, and held in&nbsp;co-operation with a large and diverse set of organisations:&nbsp;Ethos in Fukushima,&nbsp;French Institute of Radiation Protection and Nuclear Safety*, French Nuclear&nbsp;Safety Authority*, Fukushima&nbsp;Medical University, Fukushima Prefecture, Japan&nbsp;Health Physics Society, Japanese Cabinet Office (Support Team for Residents&nbsp;Affected by Nuclear Incidents), Japanese Nuclear Regulation Authority, Ministry&nbsp;of the Environment of Japan, The Nippon&nbsp;Foundation*, Norwegian Radiation&nbsp;Protection Authority*, OECD Nuclear Energy Agency*, and Radiation Safety&nbsp;Forum Japan&nbsp;(those marked with an asterisk also provided the financial support&nbsp;necessary to make this event a reality, and the resulting&nbsp;proceedings freely available).&nbsp; Special thanks to all involved.</p> Thu, 12 Oct 2017 06:27:09 +0000 First Announcement of Joint ICRP-RERF-JHPS Workshop on Recent Progress in Radiation Dosimetry for Epidemiology and Radiological Protection http://www.icrp.org/docs/Joint ICRP-RERF-JHPS Workshop Dec 2017 First Announcement.pdf http://www.irpa.net/docs/Joint ICRP-RERF-JHPS Workshop Dec 2017 First Announcement.pdf Thu, 12 Oct 2017 13:10:14 +0000 ICRP Announces 90th Anniversary Drive to Free the Annals http://www.icrp.org/page.asp?id=362 <p class="MsoNormal"><span>Today in Paris, ICRP Chair Claire Cousins announced the organisation&rsquo;s intention to begin the process of making the Annals of the ICRP free-to-access for everyone around the world.</span><span>&nbsp; </span><span>By making all but the most recent two years available, professionals, governments, and the public stand to benefit.</span></p> <p class="MsoNormal"><span>At the opening ceremonies of ICRP-ERPW 2017, Dr. Cousins recognised the support of the UAE Federal Authority for Nuclear Regulation (FANR) and the United States Department of Energy (DOE) for kickstarting the campaign with generous financial contributions, enabling free access to ICRP Publication 103: The 2007 Recommendations of the International Commission on Radiological Protection.</span></p> <p class="MsoNormal"><em><span lang="EN-US">&ldquo;</span></em><em><span>We are delighted to lead the way with a meaningful contribution towards making the Annals of the ICRP available for free, and in particular we are proud that Publication 103 is now available to everybody thanks to our contribution. Easy access will be a boon to governments, scientists, professionals, and interested citizens world-wide. Let&rsquo;s take on this important initiative together.</span></em><em><span lang="EN-US">&rdquo;</span></em></p> <p class="MsoNormal"><strong><span lang="EN-US">- </span></strong><strong><span>Christer Viktorsson, Director General, The UAE&rsquo;s Federal Authority for Nuclear Regulation (FANR)</span></strong></p> <p class="MsoNormal"><em><span lang="EN-US">&ldquo;We are pleased to join other agencies and countries in ICRP&rsquo;s efforts with our contribution towards making the Annals of the ICRP available for free; and, in particular, we are thrilled that Publication 103 will be available to everyone. &nbsp;Access will be a benefit to radiation protection professionals, scientists, and interested countries worldwide. &nbsp;Let us undertake this critical initiative together.&rdquo;</span></em></p> <p class="MsoNormal"><span lang="EN-US">- <strong>Dr. Patricia R. Worthington, Director, Office of Health and Safety, United States Department of Energy</strong></span></p> <p class="MsoNormal"><span>In 2016, ICRP set three strategic priorities:</span></p> <ul> <li>Maintain and Continue to Improve the System of Radiological Protection</li> <li><span style="text-indent: -18pt; font-size: 10pt;">Promote Awareness of Radiological Protection and Broaden Access to ICRP Recommendations</span></li> <li><span style="text-indent: -18pt; font-size: 10pt;">Increase Engagement with Professionals, Policy-Makers, and the Public</span></li> </ul> <p class="MsoNormal"><span>This initiative addresses all of these priorities heading into the charity&rsquo;s 90<sup>th</sup> year and beyond. Thanks to FANR and the DOE, and others who will follow their lead, the future looks bright.</span></p> <p><span style="font-size: 10pt;">Parties interested in joining this important initiative are encouraged to contact </span><a style="background-color: #ffffff; font-size: 10pt;" href="mailto:kelsey.cloutier@icrp.org">Kelsey Cloutier</a><span style="font-size: 10pt;">, Development and Communications Manager.</span></p> Tue, 10 Oct 2017 09:30:10 +0000 ICRP Workshop Nov 2017 First Announcement http://www.icrp.org/docs/ICRP Workshop Nov 2017 First Announcement.pdf http://www.irpa.net/docs/ICRP Workshop Nov 2017 First Announcement.pdf Tue, 10 Oct 2017 13:43:15 +0000 Joint FMU-ICRP Workshop on Radiological Protection in Medicine http://www.icrp.org/page.asp?id=361 <p>On Tuesday October 3, 2017, ICRP, in conjunction with Fukushima Medical University, put on a joint symposium on Radiological Protection in Medicine.</p> <h3>Opening Address</h3> <p>Koichi Tanigawa (Fukushima Medical University, Japan)&nbsp;<br /><br /></p> <h3>Session 1: General Overview and Introduction from FMU</h3> <p><a href="docs/2017fuk/1%20Yonekura%20Presentation.pdf">Radiological Protection in Medicine: Overview and Introduction of TG101</a><br />Yoshiharu Yonekura (QST, Japan)&nbsp;<br /><br /><a href="docs/2017fuk/2%20Oriuchi%20Presentation.pdf">New Treatment Facility and Targeted Alpha-particle Therapy in FMU</a><br />Noboru Oriuchi (Fukushima Medical University, Japan)&nbsp;<br /><br /></p> <h3>Session 2: Risk Estimate for Radiological Protection</h3> <p><a href="docs/2017fuk/3%20Mattsson%20Presentation.pdf">Individual Risk Estimates in Radiology: Is it necessary and possible?</a>&nbsp;<br />S&ouml;ren Mattsson (Sk&aring;ne University Hospital Malm&ouml; and Lund University, Sweden)&nbsp;<br /><br /><a href="docs/2017fuk/4%20Bolch%20Presentation.pdf">Pediatric Phantoms for Dosimetry Calculations</a>&nbsp;<br />Wesley Bolch (University of Florida, USA)&nbsp;<br /><br /></p> <h3>Session 3: Radiological Protection in Radionuclide Therapy</h3> <p><a href="docs/2017fuk/5%20Flux%20Presentation.pdf">Individualized Treatment Planning in Radionuclide Therapy</a>&nbsp;<br />Glenn Flux (Royal Marsden Hospital, UK)&nbsp;<br /><br /><a href="docs/2017fuk/6%20Hosono%20Presentation.pdf">Current Status on Radionuclide Therapy</a><br />Makoto Hosono (Kindai University, Japan)&nbsp;</p> <p>Many thanks to our participants and speakers for a successful and engaging event.</p> <p>Further information, including the Abstracts, can be found&nbsp;<a href="page.asp?id=360">here</a>.</p> Mon, 9 Oct 2017 06:50:44 +0000 FMU-ICRP Workshop Third Announcement http://www.icrp.org/docs/FMU-ICRP Workshop Third Announcement.pdf http://www.irpa.net/docs/FMU-ICRP Workshop Third Announcement.pdf Mon, 18 Sep 2017 11:17:15 +0000 Release of ICRP 2016 Annual Report http://www.icrp.org/docs/Annual Report 2016.pdf http://www.irpa.net/docs/Annual Report 2016.pdf Fri, 15 Sep 2017 13:41:00 +0000 ICRP Welcomes New Intern: Laila Omar-Nazir http://www.icrp.org/page.asp?id=358 <p style="font-size: 12px;">On September 5th, ICRP welcomed Laila Omar-Nazir to the Scientific Secretariat team.</p> <p style="font-size: 12px;">Similar to past situations, the Canadian Nuclear Safety Commission (CNSC) have graciously provided this resource cost-free. &nbsp;This is her second four-month post in the CNSC co-op program, after previously completing eight months at Ontario Power Generation, working out of the Darlington Station in Bowmnaville, Ontario.</p> <p style="font-size: 12px;">A native of Newmarket, Laila is in her fourth year at McMaster Univeristy, with one more semester left before a BSc in Medical and Health Physics.</p> <p style="font-size: 12px;">While at ICRP, Laila will be assisting in the completion of various tasks, including learning objectives for future students in the program.</p> <p style="font-size: 12px;">Once again, thank you to the CNSC for their partnership, collaboration, and support.</p> <p style="font-size: 12px;">Welcome Laila!</p> Tue, 12 Sep 2017 13:10:40 +0000 Fukushima Medical University-ICRP Workshop Abstract http://www.icrp.org/docs/FMU-ICRP Workshop Abstract.pdf http://www.irpa.net/docs/FMU-ICRP Workshop Abstract.pdf Fri, 11 Aug 2017 13:52:58 +0000 ICRU Releases Report NO. 91 http://www.icrp.org/docs/ICRU RELEASES REPORT NO. 91.pdf http://www.irpa.net/docs/ICRU RELEASES REPORT NO. 91.pdf Tue, 8 Aug 2017 13:36:14 +0000 Changes in Committee 3 Leadership http://www.icrp.org/page.asp?id=357 <p>Donald Milller, who had been elected to the ICRP Main Commission as Committee 3 Chair, has resigned due to a conflict of interest between his duties as a trustee of ICRP and his obligations to his employer, the US Food and Drug Administration.</p> <p>Colin Martin, ICRP Committee 3 Vice-Chair, is leading the Committee until election of a new Chair.</p> <p>Election of a new Committee 3 Chair will take place during the next meeting of the Main Commission, to be held October 6-8, 2017. This is immediately prior to the 4th International Symposium on the System of Radiological Protection and the 2nd European Radiological Protection Research Week (<a title="ICRP-ERPW 2017" href="http://www.icrp-erpw2017.com/" target="_blank">ICRP-ERPW 2017</a>), taking place in Paris, October 10-12.</p> Thu, 3 Aug 2017 22:20:12 +0000 Draft Joint Report of ICRU and ICRP for Consultation: Operational Quantities for External Radiation Exposure http://www.icrp.org/page.asp?id=356 <p><span style="font-size: 10pt;">The draft </span><strong style="font-size: 10pt;">ICRU and ICRP report Operational Quantities for External Radiation Exposure</strong><span style="font-size: 10pt;"> is now available for public consultation.&nbsp; We welcome comments from individuals and organisations.&nbsp; The draft document can be downloaded from the ICRP website.&nbsp; Comments must be submitted through the ICRP website no later than </span><strong style="font-size: 10pt;">November 3, 2017</strong><span style="font-size: 10pt;">.</span></p> <p class="MsoNormal">&nbsp;</p> <p class="MsoNormal">&nbsp;</p> <p class="MsoNormal"><strong>Abstract</strong></p> <p>&nbsp;</p> <p class="MsoNormal">The Commission defines a set of&nbsp;operational dose quantities for the determination of the exposure of external&nbsp;radiation by measurement or calculation. These assessments serve as estimates of&nbsp;values&nbsp;of the protection quantities defined by the International Commission on&nbsp;Radiological Protection (ICRP) that are generally not measurable. The set of&nbsp;ICRU operational dose quantities in current use&nbsp;was defined 30 years ago. The&nbsp;rationale for operational quantities has been examined taking into account the&nbsp;recent changes in the definitions of the protection quantities (ICRP, 2010);&nbsp;the changes in&nbsp;the fields of application of the operational quantities and&nbsp;protection quantities in medicine, scientific research, and natural sources of&nbsp;radiation; and the extension of types of particles and range of&nbsp;energies&nbsp;contributing to doses to workers and members of the public. The previous&nbsp;operational quantities were based on the dose equivalent that would be produced&nbsp;at a depth in the hypothetical&nbsp;ICRU 4-element sphere, and on dose equivalent in&nbsp;soft tissue at a point in the body. The investigations which have been carried&nbsp;out that have led to the recommendations given in this Report have&nbsp;included the&nbsp;study the values of weighted absorbed doses at different depths in&nbsp;tissue-equivalent phantoms and the combination of different depths. The&nbsp;operational quantities recommended in this&nbsp;Report are defined in terms of radiometric&nbsp;and dosimetric quantities at a point in space multiplied by values of&nbsp;conversion coefficients to the protection quantities, effective dose, absorbed&nbsp;dose in the&nbsp;lens of the eye, and absorbed dose in local skin, calculated for&nbsp;broad parallel beams incident on the body. The relationship of the recommended&nbsp;operational quantities to the protection quantities has&nbsp;been investigated. The&nbsp;impact of changes on routine measurement practice, including instrument design and&nbsp;calibration has been considered.</p> <p class="MsoNormal">While this will be published by ICRU, questions and inquiries can be directed to <a href="mailto:kelsey.cloutier@icrp.org">Kelsey Cloutier</a>, Development and Communications Manager for ICRP.</p> Wed, 2 Aug 2017 11:45:56 +0000 Release of Publication 134: Occupational Intakes of Radionuclides: Part 2 http://www.icrp.org/page.asp?id=354 <h1>Occupational Intakes of Radionuclides: Part 2</h1> <h2>ICRP Publication 134</h2> <p><span style="font-size: 12px;">Ann. ICRP 45(3/4), 1&ndash;352, 2016</span><br style="font-size: 12px;" /><br style="font-size: 12px;" /><span style="font-size: 12px;">F. Paquet, M.R. Bailey, R.W. Leggett, J. Lipsztein, T.P. Fell,T. Smith, D. Nosske, K.F. Eckerman, V. Berkovski, E. Ansoborlo,A. Giussani, W.E. Bolch, J.D. Harrison</span><br style="font-size: 12px;" /><br style="font-size: 12px;" /><br style="font-size: 12px;" /><strong style="font-size: 12px;">Abstract -</strong><span style="font-size: 12px;">&nbsp;The 2007 Recommendations of the International Commission on Radiological Protection (ICRP, 2007) introduced changes that affect the calculation of effective dose, and implied a revision of the dose coefficients for internal exposure, published previously in thePublication 30series (ICRP, 1979, 1980, 1981, 1988b) and Publication 68(ICRP, 1994b). In addition, new data are available that support an update of the radionuclide-specific information given in Publications 54 and 78 (ICRP, 1988a, 1997b) for the design of monitoring programmes and retrospective assessment of occupational internal doses. Provision of new biokinetic models, dosecoefficients, monitoring methods, and bioassay data was performed by Committee 2, Task Group 21 on Internal Dosimetry, and Task Group 4 on Dose Calculations. A new series, the Occupational Intakes of Radionuclides (OIR) series, will replace the Publication 30series and Publications 54,68, and 78. Part 1 of the OIR series has been issued (ICRP, 2015), and describes the assessment of internal occupational exposure to radionuclides, biokinetic and dosimetric models, methods of individual and workplace monitoring, and general aspects of retrospective dose assessment. The following publications in the OIR series (Parts 2&ndash;5) will provide data on individual elements and their radioisotopes, including information on chemical forms encountered in the workplace; a list of principal radioisotopes and their physical half-lives and decay modes; the parameter values of the reference biokinetic model; and data on monitoring techniques for the radioisotopes encountered most commonly in workplaces. Reviews of data on inhalation, ingestion, and systemic biokinetics are also provided for most of the elements. Dosimetric data provided in the printed publications of the OIR series include tables of committed effective dose perintake (Sv per Bq intake) for inhalation and ingestion, tables of committed effective dose per content (Sv per Bq measurement) for inhalation, and graphs of retentionand excretion data per Bq intake for inhalation. These data are provided for all absorption types and for the most common isotope(s) of each element. The electronic annex that accompanies the OIR series of reports contains a comprehensive set of committed effective and equivalent dose coefficients, committed effective dose percontent functions, and reference bioassay functions. Data are provided for inhalation, ingestion, and direct input to blood. The present publication provides the above data for the following elements: hydrogen (H), carbon (C), phosphorus (P),sulphur (S), calcium (Ca), iron (Fe), cobalt (Co), zinc (Zn), strontium (Sr), yttrium(Y), zirconium (Zr), niobium (Nb), molybdenum (Mo), and technetium (Tc).</span><br style="font-size: 12px;" /><br style="font-size: 12px;" /></p> <h3>Recommended reference format for citations</h3> <p><span style="font-size: 12px;">ICRP, 2016. Occupational intakes of radionuclides: Part 2. ICRP Publication 134. Ann. ICRP 45(3/4), 1&ndash;352.</span><br style="font-size: 12px;" /></p> Tue, 11 Jul 2017 12:47:30 +0000 ICRP Research Priorities 2017 http://www.icrp.org/docs/ICRP Research Priorities 2017.pdf http://www.irpa.net/docs/ICRP Research Priorities 2017.pdf Tue, 27 Jun 2017 17:56:44 +0000 Joint FMU-ICRP Workshop on Radiological Protection in Medicine http://www.icrp.org/docs/Joint FMU-ICRP Workshop Oct 2017 First Announcement.pdf http://www.irpa.net/docs/Joint FMU-ICRP Workshop Oct 2017 First Announcement.pdf Thu, 22 Jun 2017 13:38:37 +0000 ICRP Announces Committee Membership for 2017-2021 http://www.icrp.org/page.asp?id=353 <p class="MsoNormal"><span>In December 2016, ICRP advertised an open call for nominations for Committee membership for the coming term. A large number of excellent nominations were received, each of which was considered carefully by all Main Commission members. We sincerely thank everyone who was nominated for their interest in ICRP.</span></p> <p class="MsoNormal"><span>Last May, the Main Commission voted to select those to be invited to be Committee members for the July 1, 2017 to June 30, 2021 term. Invitations were sent, as were letters of thanks to those who were not elected. Those not elected will be considered when looking for specific expertise for ICRP Task Groups.</span></p> <p class="MsoNormal"><span>It is with great enthusiasm that we welcome and congratulate the following individuals who have accepted their invitations to join an ICRP Committee:</span></p> <p class="MsoNormal"><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Committee 1 (Radiation Effects)</strong></span></p> <p class="MsoListParagraphCxSpFirst" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Werner R&uuml;hm (Chair)</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Tamara Azizova</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Ranajit Chakraborty</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Wolfgang D&ouml;rr</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Jaqueline Garnier-Laplace</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Michael Hauptmann</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Kotaro Ozasa</span></p> <p>&nbsp; Preetha Rajarama</p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Kazuo Sakai</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Sisko Salomaa</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Mikhail Sokolnikov</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Daniel Stram</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Quanfu Sun</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Richard Wakeford</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Andrzej Wojcik</span></p> <p class="MsoListParagraphCxSpLast" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Gayle Woloschak</span></p> <p class="MsoNormal" style="margin-left: 36.0pt;"><strong><span>Committee 2 (Doses from Radiation Exposure)</span></strong></p> <p class="MsoListParagraphCxSpFirst" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>John Harrison (Chair)</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Volodymyr Berkovski</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Eric Blanchardon</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Wesley Bolch</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Fran&ccedil;ois Paquet</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Augusto Giussani</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Nina Petoussi-Hen&szlig;</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Derek Jokisch</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Chan Hyeong Kim</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Rich Leggett</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Maria Lopez</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Junli Li</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Tatsuhiko Sato</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Tracy Smith</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Alexander Ulanowski</span></p> <p class="MsoListParagraphCxSpLast" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Frank Wissmann</span></p> <p class="MsoNormal" style="margin-left: 36.0pt;"><strong><span>Committee 3 (Protection in Medicine)</span></strong></p> <p class="MsoListParagraphCxSpFirst" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Donald Miller (Chair)</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Jamila Al Suwaidi</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Kimberly Applegate</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Michel Bourguignon</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Marie-Claire Cantone</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Sandor Demeter</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Makoto Hosono</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Keon Wook Kang</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Reinhard Loose</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Josep Mart&iacute;-Climent</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Colin Martin</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Yantao Niu</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Madan Rehani</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>William Small</span></p> <p class="MsoListParagraphCxSpLast" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>David Sutton</span></p> <p class="MsoNormal" style="margin-left: 36.0pt;"><strong><span>Committee 4 (Application of the Commission&rsquo;s Recommendations)</span></strong></p> <p class="MsoListParagraphCxSpFirst" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Donald Cool (Chair)</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Nobuhiko Ban</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Fran&ccedil;ois Bochud</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Michael Boyd</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Analia Canoba</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>David Copplestone</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Eduardo Gallego</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Kathryn Higley</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Gillian Hirth</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Toshimitsu Homma</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Catrin Koch</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Jean-Fran&ccedil;ois Lecomte</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Yahong Mao</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Nicole Martinez</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Anne Nisbet</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Thierry Schneider</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Sergey Shinkarev</span></p> <p class="MsoListParagraphCxSpLast" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>John Takala</span></p> <p class="MsoNormal" style="margin-top: 12.0pt;"><span>As announced last <a href="docs/Committees%20Announcement.pdf">November</a>, ICRP is working to further integrate protection of people and the environment. To reflect this, Committees 1, 2, and 4 are taking on responsibilities in radiological protection of the environment formerly undertaken by Committee 5.</span></p> <p class="MsoNormal"><span>A decision was made to begin the term with a slightly smaller overall Committee membership than before. This will make it easier to take advantage of opportunities during the term to add a few members to include particular expertise, or to further improve geographical and gender balance. </span></p> <p class="MsoNormal"><span>Please note that a few members-elect are still in the process of accepting their invitations, so a few additions may still be made to the Committee membership listed above.</span></p> <p class="MsoNormal"><span>Questions can be directed to <a href="mailto:kelsey.cloutier@icrp.org">Kelsey Cloutier</a>, ICRP Development and Communications Manager.</span></p> Wed, 21 Jun 2017 16:37:43 +0000 Summary of May 2017 Main Commission Meeting Lima http://www.icrp.org/docs/Summary of May 2017 Main Commission Meeting Lima.pdf http://www.irpa.net/docs/Summary of May 2017 Main Commission Meeting Lima.pdf Mon, 12 Jun 2017 13:54:53 +0000